Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
JAMA Network Open|August 25, 2022
Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti-PD-1 EraNayan Lamba, Patrick A Ott, J Bryan Iorgulescu
Neuro-Oncology Practice|March 27, 2023
The predictive value of partial MGMT promoter methylation for IDH-wild-type glioblastoma patientsMatthew Torre, Patrick Y Wen, J Bryan Iorgulescu
Pathology|January 12, 2024
Predictive and prognostic molecular biomarkers in lymphomasJ Bryan Iorgulescu, L Jeffrey Medeiros, Keyur P Patel
JCO Precision Oncology|May 30, 2024
Expanding the Reach of Personalized Medicine in Cancer Care: Current Progress and Future Directions of JCO Precision OncologyYushu Shi, J Bryan Iorgulescu, Stephanie Valladao, et al.
JCO Precision Oncology|January 30, 2023
The Prevalence and Prognosis of Microsatellite Instability-High/Mismatch Repair-Deficient Colorectal Adenocarcinomas in the United StatesCatherine Gutierrez, Shuji Ogino, Jeffrey A Meyerhardt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 29, 2022
Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Advanced Colorectal CancerDavid J Papke, Neal I Lindeman, Deborah Schrag, et al.
Neurocritical Care|December 19, 2014
Incidence, Timing, and Predictors of Delayed Shunting for Hydrocephalus After Aneurysmal Subarachnoid HemorrhageBrian P Walcott, J Bryan Iorgulescu, Christopher J Stapleton, et al.
Journal of Neuroimmunology|December 30, 2015
The limited capacity of malignant glioma-derived exosomes to suppress peripheral immune effectorsJ Bryan Iorgulescu, Michael E Ivan, Michael Safaee, et al.
Journal of Neuro-Oncology|January 17, 2022
The epidemiology of primary and metastatic brain tumors in infancy through childhoodNayan Lamba, Andrew Groves, Matthew Torre, et al.
Journal of Neuro-Oncology|April 27, 2022
Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patientsVasileios K Kavouridis, Keith L Ligon, Patrick Y Wen, et al.
Pageof 8